Leaflet BOOSTRIX-IPV suspension for injection in pre-filled syringe
Indicated for: prevention of diphtheria, tetanus and pertussis
Route of administration: injectable
Substance: diphtheria + tetanus + pertussis + polio vaccine inactivated (vaccine)
ATC: J07CA02 (Antiinfectives for systemic use | Bacterial and viral vaccines, combined)
Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.
This medicine is subject to additional monitoring.
Store in the refrigerator as instructed in the leaflet.
Store protected from light.
The diphtheria, tetanus, pertussis, inactivated polio (DTP-IPV) vaccine is used to prevent diphtheria, tetanus, whooping cough (pertussis), and poliomyelitis, four serious infectious diseases caused by bacteria and viruses. The vaccine contains diphtheria and tetanus toxoids, inactivated or purified components of Bordetella pertussis, and inactivated poliovirus, which stimulate the immune system to produce specific antibodies against these pathogens.
The vaccine is administered intramuscularly, usually in multiple doses, according to recommended vaccination schedules for infants and young children. Booster doses are required at regular intervals to maintain immunity.
Common side effects include pain at the injection site, mild fever, fatigue, and irritability. In rare cases, severe allergic reactions may occur.
The DTP-IPV vaccine is an essential measure for protecting public health, helping to reduce the incidence and severity of these infectious diseases and prevent the severe complications associated with them.
General data about BOOSTRIX-IPV
- Substance: diphtheria + tetanus + pertussis + polio vaccine inactivated
- Date of latest medicines list: 01-04-2022
- Product code: W59173002
- Pharmaceutical form: suspension for injection in pre-filled syringe
- Quantity: 1
- Product type: Original
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.